Beverly Hills, CA (PRWEB) June 26, 2014 -- A new study published in the journal Medical Science Monitor has found that patients who have high levels of Epstein-Barr virus (EBV) antibodies can benefit from intravenous vitamin C. The researchers, Nina A. Mikirova and Ronald Hunninghake of Wichita's Riordan Clinic, looked at data from 35 patients who had high levels of Epstein-Barr virus antibodies. They measured the level of antibodies before and after the administration of high-dose intravenous vitamin C. The results showed that patients with five or more infusions of vitamin C experienced a significant decrease in antibodies.
Epstein-Barr virus is a very common virus. While most people get it at some point in their lives, having a high level of antibodies to the virus has been implicated in the development of a number of diseases and conditions, ranging from mononucleosis to multiple sclerosis.
“What this study shows is that vitamin C may actually be useful in reducing the number of Epstein-Barr virus antibodies in patients,” explained Dr. Arash Bereliani, a board certified cardiologist and the founder of the IV Therapy Center in Beverly Hills. “This is the first time that this particular application of vitamin C has been shown through a clinical study.”
The Epstein-Barr virus is part of the herpes family. Estimates say that as many as 95% of Americans between the ages of 35 and 40 have been infected with it at some point. EBV is spread through contact with saliva from the mouth of someone who has the virus. Common symptoms of EBV include:
● Sore throat
● Swollen lymph nodes
About Intravenous Vitamin C
In addition to treating Epstein-Barr virus, high-dose vitamin-C is also useful for treating a broad variety of diseases and conditions. Some of the most common of these are:
● Surgical wounds
“The advantage of taking intravenous vitamin C is that it can be administered at high doses without side effects,” said Dr. Bereliani. “When ingested orally, high dose vitamin C will usually cause patients unpleasant symptoms such as upset stomach and diarrhea. However, through IV therapy, Beverly Hills patients are able to safely absorb a much higher amount than they otherwise would be able to take.”
About Dr. Bereliani
Arash Bereliani, MD, FACC, is a Beverly Hills physician board certified in cardiology and internal medicine. Dr. Bereliani currently serves as a cardiologist on staff in the Division of Cardiology at the world-renowned Cedars-Sinai Heart Institute. He is also a clinical instructor at UCLA’s David Geffen School of Medicine. Dr. Bereliani’s academic duties involve teaching as well as conducting original research on nuclear cardiology and cardiac imaging. His areas of interest include cardiac imaging, cardiac diseases, preventative cardiology, and integrative cardiology, and IV vitamin therapy for health optimization.
To learn more about Dr. Bereliani and the IV Therapy Center of Beverly Hills, visit his website http://ivtherapycenter.com/.
Risa Goldman, Goldman Marketing Group, +1 818-861-7092, [email protected]